Pages that link to "Q34322179"
Jump to navigation
Jump to search
The following pages link to Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors (Q34322179):
Displaying 50 items.
- Zotepine versus other atypical antipsychotics for schizophrenia (Q24234683) (← links)
- Olanzapine IM or velotab for acutely disturbed/agitated people with suspected serious mental illnesses (Q24244015) (← links)
- Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders (Q24632508) (← links)
- Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo (Q24647996) (← links)
- Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-Hydroxytryptamine7 receptor by risperidone, 9-OH-Risperidone, and other inactivating antagonists (Q24656286) (← links)
- [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum (Q24672411) (← links)
- Characterization of [(125)I]-SB-258585 binding to human recombinant and native 5-HT(6) receptors in rat, pig and human brain tissue (Q24674871) (← links)
- Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT(2B) receptors (Q24675027) (← links)
- In vivo effects of the 5-HT(6) antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate (Q24675069) (← links)
- Genome-wide association discoveries of alcohol dependence (Q27003168) (← links)
- Targeting the Serotonin 5-HT7 Receptor in the Search for Treatments for CNS Disorders: Rationale and Progress to Date (Q28084125) (← links)
- 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells (Q28186620) (← links)
- Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro (Q28253277) (← links)
- 5-HT6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease (Q28287100) (← links)
- Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding (Q28297725) (← links)
- [(3)H]-SB-269970--A selective antagonist radioligand for 5-HT(7) receptors (Q28344255) (← links)
- An endogenous 5-HT(7) receptor mediates pigment granule dispersion in Xenopus laevis melanophores (Q28363071) (← links)
- In Vitro and In Vivo Characterization of the Alkaloid Nuciferine (Q28550683) (← links)
- A 5-HT7 heteroreceptor-mediated inhibition of [3H]serotonin release in raphe nuclei slices of the rat: evidence for a serotonergic-glutamatergic interaction (Q28584167) (← links)
- Structure and function of serotonin G protein-coupled receptors. (Q30382524) (← links)
- The presynaptic component of the serotonergic system is required for clozapine's efficacy. (Q30471071) (← links)
- Molecular targets for treating cognitive dysfunction in schizophrenia. (Q30491310) (← links)
- Inactivation of the 5-HT(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition (Q30491859) (← links)
- Modulation of midbrain dopamine neurotransmission by serotonin, a versatile interaction between neurotransmitters and significance for antipsychotic drug action (Q30493995) (← links)
- Olanzapine: an updated review of its use in the management of schizophrenia (Q32058541) (← links)
- Label-free cell phenotypic profiling decodes the composition and signaling of an endogenous ATP-sensitive potassium channel (Q33595477) (← links)
- Metabolic hormones, dopamine circuits, and feeding (Q33620754) (← links)
- Theranostic Biomarkers for Schizophrenia (Q33624412) (← links)
- The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior (Q33706833) (← links)
- The 5-HT7 receptor and disorders of the nervous system: an overview (Q33738349) (← links)
- The human serotonin-7 receptor pseudogene: variation and chromosome location (Q33922086) (← links)
- 5-HT7 receptors as modulators of neuronal excitability, synaptic transmission and plasticity: physiological role and possible implications in autism spectrum disorders (Q34093279) (← links)
- Atypical neuroleptics in child and adolescent psychiatry (Q34120084) (← links)
- Knowledge-based analysis of multi-potent G-protein coupled receptors ligands (Q34142607) (← links)
- Role of the 5-HT7 Receptor in the Central Nervous System: from Current Status to Future Perspectives (Q34172419) (← links)
- Serotonin receptors and heart valve disease--it was meant 2B. (Q34173511) (← links)
- Effects of geissoschizine methyl ether, an indole alkaloid in Uncaria hook, a constituent of yokukansan, on human recombinant serotonin 7 receptor (Q34299127) (← links)
- Synthesis and structure-activity relationship studies of N-benzyl-2-phenylpyrimidin-4-amine derivatives as potent USP1/UAF1 deubiquitinase inhibitors with anticancer activity against nonsmall cell lung cancer (Q34313778) (← links)
- Pulicatins A−E, Neuroactive Thiazoline Metabolites from Cone Snail-Associated Bacteria (Q34361083) (← links)
- D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs (Q34367551) (← links)
- Clinical significance of pharmacogenomic studies in tardive dyskinesia associated with patients with psychiatric disorders (Q34391577) (← links)
- Evidence for 5-HT2B and 5-HT7 receptor-mediated relaxation in pulmonary arteries of weaned pigs (Q34650329) (← links)
- Differential profile of typical, atypical and third generation antipsychotics at human 5-HT7a receptors coupled to adenylyl cyclase: detection of agonist and inverse agonist properties. (Q34677182) (← links)
- SB-258741: a 5-HT7 receptor antagonist of potential clinical interest. (Q34692022) (← links)
- Binding of serotonin and N1-benzenesulfonyltryptamine-related analogs at human 5-HT6 serotonin receptors: receptor modeling studies (Q34737074) (← links)
- In vitro serotonergic activity of black cohosh and identification of N(omega)-methylserotonin as a potential active constituent (Q34892506) (← links)
- Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist (Q35042314) (← links)
- Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonist (Q35042511) (← links)
- Autoradiographic distribution of 5-HT7 receptors in the human brain using [3H]mesulergine: comparison to other mammalian species (Q35046003) (← links)
- Increased expression of 5-HT₆ receptors in dorsolateral striatum decreases habitual lever pressing, but does not affect learning acquisition of simple operant tasks in rats (Q35112806) (← links)